Verici Dx plc (LON:VRCI – Get Free Report) shares traded up 14% during trading on Friday . The company traded as high as GBX 2.93 ($0.04) and last traded at GBX 2.85 ($0.04). 1,706,122 shares were traded during mid-day trading, an increase of 75% from the average session volume of 975,578 shares. The stock had previously closed at GBX 2.50 ($0.03).
Verici Dx Stock Up 15.0 %
The company has a market capitalization of £8.73 million, a P/E ratio of -1.67 and a beta of 1.59. The company has a quick ratio of 8.49, a current ratio of 4.54 and a debt-to-equity ratio of 4.64. The company has a 50-day moving average of GBX 3.20 and a two-hundred day moving average of GBX 3.89.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Top 3 Beverage Stocks Pouring Out Profits
- Transportation Stocks Investing
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
